Eurofins Competitors

Stocks . France . 
Stock . Eurofins Cerep SA
ALECR Stock  EUR 16,100  1,700  9.55%   
Eurofins Cerep SA competes with AB Science, Affluent Medical, Mediantechn, Sensorion, and Biosynex; as well as few others. The company operates under Life Sciences Tools & Services sector and is part of Health Care industry. Analyzing Eurofins Cerep competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eurofins Cerep to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Eurofins Cerep Correlation with its peers.

Eurofins Cerep vs ALGAE Correlation

Very good diversification

The correlation between Eurofins Cerep SA and ALGAE is -0.21 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eurofins Cerep SA and ALGAE in the same portfolio, assuming nothing else is changed.

Moving together with Eurofins Stock

  0.62GNFT Genfit SAPairCorr

Moving against Eurofins Stock

  0.51ALTHE Theradiag SAPairCorr
  0.32ALSGD SpineguardPairCorr
Hype
Prediction
LowEstimatedHigh
16,09816,10016,102
Details
Intrinsic
Valuation
LowRealHigh
14,49016,52516,527
Details
Naive
Forecast
LowNextHigh
15,24715,24915,251
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
16,19017,36918,547
Details

Eurofins Cerep Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eurofins Cerep and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eurofins and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eurofins Cerep SA does not affect the price movement of the other competitor.

High positive correlations

ALMDT
+ 0.9
AB
MAAT
+ 0.87
AB
ALMDT
+ 0.76
AFME
ALMDT
+ 0.74
MAAT
AFME
+ 0.72
AB
AFME
+ 0.64
MAAT
  

High negative correlations

ALMDT
- 0.78
ALKLH
AFME
- 0.74
ALKLH
AB
- 0.74
ALKLH
MAAT
- 0.65
ALKLH
ALPRE
- 0.54
ALSEN
ALSEN
- 0.52
ALMDT

Risk-Adjusted Indicators

There is a big difference between Eurofins Stock performing well and Eurofins Cerep Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eurofins Cerep's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ALKLH  1.54 (0.24) 0.00 (0.24) 0.00 
 0.00 
 4.35 
(4.17)
 8.89 
AB  1.94  0.22  0.06  3.48  1.83 
(2.90)
 5.17 
(3.39)
 13.65 
MAAT  3.02  0.38  0.08  1.93  3.47 
(3.52)
 8.74 
(6.46)
 26.11 
AFME  2.91  0.43  0.16  0.37  2.54 
(4.43)
 6.54 
(4.00)
 47.23 
ALMDT  3.63  0.58  0.14  0.88  3.57 
(4.27)
 6.80 
(5.92)
 25.17 
ALSEN  2.77 (0.21) 0.00 (0.47) 0.00 
 0.00 
 6.06 
(5.88)
 19.05 
ALBIO  2.64  0.26  0.04 (0.36) 2.27 
(5.33)
 7.35 
(4.41)
 24.94 
ALCJ  2.34 (0.33) 0.00 (0.29) 0.00 
 0.00 
 5.85 
(5.07)
 15.77 
ALPRE  1.87  0.16  0.00 (0.11) 2.16 
(2.79)
 5.32 
(3.54)
 22.75 
ALGAE  2.15 (0.12)(0.03) 0.00  2.21 
(3.39)
 4.76 
(4.44)
 13.30 

Eurofins Cerep Competitive Analysis

The better you understand Eurofins Cerep competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eurofins Cerep's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eurofins Cerep's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALECR ALKLH AB MAAT AFME ALMDT ALSEN ALBIO ALCJ ALPRE
 9.55 
 16,100 
Eurofins
 4.35 
 0.22 
KLEA
 5.11 
 1.44 
AB Science
 3.92 
 5.30 
Maat
 2.21 
 1.85 
Affluent
 6.39 
 4.66 
Mediantechn
 3.45 
 0.30 
Sensorion
 1.33 
 0.74 
Biosynex
 2.02 
 2.02 
Crossject
 2.07 
 3.31 
Predilife
Market Volatility
(90 Days Market Risk)
Very steady
Out of control
Very risky
Unstable
Dangerous
Unstable
Out of control
Abnormally volatile
Very risky
Unstable
Market Performance
(90 Days Performance)
Weakest
Weakest
Fair
Fair
Fair
Good
Weakest
Mild
Weakest
Soft
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Unknown
Low
Unknown
Average
Low
Low
Low
Low
Average
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Hold
Strong Sell
Hold
Strong Sell
Cautious Hold
Strong Hold
Strong Sell
Strong Sell
Sell
Strong Sell
Current Ratio
3.95
N/A
1.08
N/A
N/A
2.09
13.47
1.94
2.6
3.47
Net Asset
59.73 M
N/A
21.27 M
N/A
70.03 M
49.39 M
59.09 M
268.94 M
31.52 M
3.97 M
Profit Margin
0.24
N/A
N/A
N/A
N/A
-0.8
N/A
0.21
-1.74
N/A
EBITDA
10.85 M
N/A
(11.14 M)
N/A
(9.87 M)
(16.98 M)
(14.64 M)
139.33 M
(6.7 M)
(3.49 M)
Operating Margin
0.23
N/A
-12.22
N/A
-8.42
-0.77
-4.64
0.3
-1.95
-12.32
Current Valuation
106.92 M
N/A
427.66 M
N/A
50.42 M
117.65 M
(3.6 M)
91.77 M
123.81 M
22.91 M
Price To Book
2.2
N/A
N/A
N/A
0.99
271.96
0.97
0.77
37.19
34.29
Retained Earnings
N/A
N/A
(144 M)
N/A
N/A
(4 M)
(11 M)
(5 M)
(19 M)
N/A
Current Asset
N/A
N/A
32 M
N/A
N/A
30 M
15 M
6 M
6 M
N/A
Beta
0.46
N/A
0.8
N/A
N/A
1.87
2.29
-2.01
1.3
0.24
Number Of Employees
211
N/A
100
N/A
49
191
38
320
96
14
Shares Outstanding
5.04 K
N/A
46.86 M
N/A
20.6 M
15.74 M
79.94 M
10.25 M
34.9 M
3.64 M
Cash Flow From Operations
9.48 M
N/A
(17.18 M)
N/A
(12.36 M)
(10.12 M)
(10.77 M)
109.83 M
(6.08 M)
(3.83 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
0.17
N/A
N/A
Total Debt
N/A
N/A
14.44 M
N/A
17 M
16.4 M
3.36 M
29.16 M
23.33 M
4.52 M
Return On Equity
0.24
N/A
N/A
N/A
-0.36
-5.11
-0.5
0.89
-8.32
N/A
Z Score
N/A
N/A
4.2
N/A
0.6
4.2
6.0
3.4
4.2
2.4
Return On Asset
0.12
N/A
-0.43
N/A
-0.12
-0.25
-0.24
0.45
-0.28
-0.57
Book Value Per Share
N/A
N/A
-0.63
N/A
1.95
0.031
0.55
17.24
0.09
-0.88
Current Liabilities
N/A
N/A
19 M
N/A
N/A
6 M
1000 K
4 M
1000 K
N/A
Total Asset
59.73 M
N/A
21.27 M
N/A
70.03 M
49.39 M
59.09 M
268.94 M
31.52 M
3.97 M
Target Price
1.7
N/A
19.05
N/A
3.8
34.1
2.4
37.0
6.4
N/A
Debt To Equity
N/A
N/A
102.9
N/A
N/A
N/A
0.085
17.7
105.7
3.79
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
2.0
N/A
N/A
Shares Owned By Institutions
N/A
N/A
1.8
N/A
65.0
18.72
27.0
1.58
1.72
N/A
Market Capitalization
111.98 M
N/A
314.67 M
N/A
30.06 M
130.67 M
33.81 M
121.6 M
168.21 M
22.6 M
Price To Earning
N/A
N/A
-10.99
N/A
N/A
-13.07
-4.37
48.98
-4.61
N/A
Price To Sales
2.69
N/A
193.66
N/A
22.19
5.41
6.58
0.46
18.46
78.81
Net Income
9.84 M
N/A
(14.19 M)
N/A
(14.82 M)
(19.29 M)
(15.14 M)
104 M
(10.81 M)
(3.41 M)
Earnings Per Share
2144.52
N/A
-0.43
N/A
-0.77
-1.22
-0.29
6.37
-0.37
-0.86
Shares Owned By Insiders
95.77
N/A
41.25
N/A
3.35
28.9
49.32
58.06
23.98
N/A
Revenue
41.62 M
N/A
1.61 M
N/A
N/A
20.55 M
3.34 M
382.53 M
912 K
195.9 K
Working Capital
N/A
N/A
13 M
N/A
N/A
24 M
14 M
2 M
5 M
N/A
Cash And Equivalents
783.03 K
N/A
N/A
N/A
11.41 M
39.01 M
38.03 M
1.98 M
154 K
94.9 K
Cash Per Share
N/A
N/A
0.28
N/A
N/A
1.07
0.21
0.22
0.35
0.93
Gross Profit
20.84 M
N/A
1.5 M
N/A
(1.29 M)
2.95 M
4.26 M
206.41 M
(205 K)
(3.52 M)
Day Typical Price
16100.0
0.22
1.44
5.33
1.86
4.55
0.3
0.73
2.02
3.28
Accumulation Distribution
N/A
61769.3
9188.73
11670.66
276.75
33318.03
12694.57
170.32
2682.46
169.25
Market Facilitation Index
N/A
N/A
N/A
0.0
0.0
0.0
N/A
0.0
0.0
1.0E-4
Daily Balance Of Power
0
(0.50)
1.166667
0.5263
0.8
0.8485
1.0
(0.50)
0.5714
(0.39)
Period Momentum Indicator
(1,700)
(0.01)
0.07
0.2
0.04
0.28
0.01
(0.01)
0.04
(0.07)
Rate Of Daily Change
0.9
0.96
1.05
1.04
1.02
1.06
1.03
0.99
1.02
0.98
Day Median Price
16100.0
0.22
1.44
5.35
1.87
4.5
0.3
0.73
2.03
3.26
Price Action Indicator
(850.00)
(0.01)
0.035
0.05
0.005
0.31
0.01
0.005
0.015
0.015
Coefficient Of Variation
(1,596)
(1,500)
1117.54
1101.07
993.29
707.13
(2,202)
2023.1
(1,358)
3200.23
Mean Deviation
0.5562
1.54
1.94
3.02
2.91
3.63
2.77
2.64
2.34
1.87
Jensen Alpha
(0.16)
(0.24)
0.2203
0.3816
0.4307
0.5765
(0.21)
0.2589
(0.33)
0.1638
Total Risk Alpha
(0.36)
(0.49)
(0.11)
(0.18)
(0.17)
0.0553
(0.64)
(0.35)
(0.65)
(0.32)
Sortino Ratio
N/A
N/A
0.0556
0.0818
0.1575
0.1414
N/A
0.0368
N/A
(0)
Downside Variance
N/A
N/A
5.67
14.09
9.42
15.22
N/A
9.24
N/A
7.15
Standard Deviation
1.87
2.46
2.64
4.53
5.84
4.64
3.67
4.37
3.21
3.18
Kurtosis
19.07
0.0092
0.8457
4.2
34.26
1.7
0.0258
9.89
1.8
7.61
Potential Upside
N/A
4.35
5.17
8.74
6.54
6.8
6.06
7.35
5.85
5.32
Treynor Ratio
(0.31)
(0.24)
3.48
1.93
0.3697
0.88
(0.47)
(0.36)
(0.29)
(0.11)
Maximum Drawdown
15.5
8.89
13.65
26.11
47.23
25.17
19.05
24.94
15.77
22.75
Variance
3.49
6.04
6.98
20.49
34.07
21.48
13.49
19.06
10.27
10.09
Market Risk Adjusted Performance
(0.30)
(0.23)
3.49
1.94
0.3797
0.89
(0.46)
(0.35)
(0.28)
(0.10)
Risk Adjusted Performance
(0.04)
(0.04)
0.0733
0.0754
0.0831
0.1128
(0.03)
0.0448
(0.05)
0.0308
Skewness
(3.01)
0.0673
0.7674
1.27
5.02
0.7094
0.0655
2.63
1.04
1.78
Semi Deviation
N/A
N/A
1.83
3.47
2.54
3.57
N/A
2.27
N/A
2.16
Information Ratio
(0.12)
(0.11)
0.0501
0.0678
0.0829
0.119
(0.07)
0.0256
(0.11)
(0)
Value At Risk
N/A
(4.17)
(3.39)
(6.46)
(4.00)
(5.92)
(5.88)
(4.41)
(5.07)
(3.54)
Expected Short fall
N/A
N/A
(2.90)
(3.52)
(4.43)
(4.27)
N/A
(5.33)
N/A
(2.79)
Downside Deviation
N/A
N/A
2.38
3.75
3.07
3.9
N/A
3.04
N/A
2.67
Semi Variance
N/A
N/A
3.36
12.01
6.47
12.77
N/A
5.17
N/A
4.67

Eurofins Cerep Competition Performance Charts

Five steps to successful analysis of Eurofins Cerep Competition

Eurofins Cerep's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eurofins Cerep SA in relation to its competition. Eurofins Cerep's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eurofins Cerep in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eurofins Cerep's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eurofins Cerep SA, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eurofins Cerep position

In addition to having Eurofins Cerep in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Latest Gainers Thematic Idea Now

Latest Gainers
Latest Gainers Theme
Dynamically computed list of top equities currently sorted across major exchanges. The Latest Gainers theme has 136 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Latest Gainers Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Eurofins Stock Analysis

When running Eurofins Cerep's price analysis, check to measure Eurofins Cerep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eurofins Cerep is operating at the current time. Most of Eurofins Cerep's value examination focuses on studying past and present price action to predict the probability of Eurofins Cerep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eurofins Cerep's price. Additionally, you may evaluate how the addition of Eurofins Cerep to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY